Stock Quotes & Company News |
United States

People: Mitel Networks Corp (MITL.O)

MITL.O on Nasdaq

8 Jul 2016
Change (% chg)

$1.19 (+19.77%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Matthews, Terence 

Dr. Terence Hedley Matthews is Independent Chairman of the Board of Mitel Networks Corp. He is founder, Chairman and a shareholder. Dr. Matthews has been a member of board of directors since February 16, 2001 and has been involved with the company and previously with Mitel Corporation (re-named Zarlink Semiconductor Inc. and recently acquired by Microsemi Corporation), for over 20 years. In 2001, companies controlled by Dr. Matthews purchased a controlling interest in Mitel Corporation’s communications systems division and the “Mitel” trademarks to form Mitel. Between 1986 and 2000, Dr. Matthews founded Newbridge Networks Corporation and served as its Chief Executive Officer and Chairman. Dr. Matthews is also the founder and Chairman of Wesley Clover International Corporation, an investment group with offices in the United Kingdom and Canada with investments in a broad range of next-generation technology companies, real estate and hotels and resorts. In addition, Dr. Matthews is currently Chairman, or serves on the board of directors, of a number of high technology companies including CounterPath Corporation, TrueContext Corporation, Solace Systems and DragonWave Inc. He also resigned from Bridgewater Systems Inc. in August 2011, which is now a division of Amdocs Corporation. Dr. Matthews holds an honors degree in electronics from the University of Wales, Swansea and is a Fellow of the Institute of Electrical Engineers and of the Royal Academy of Engineering. He has been awarded honorary doctorates by several universities, including the University of Wales, Glamorgan and Swansea, and Carleton University in Ottawa. In 1994, he was appointed an Officer of the Order of the British Empire, and in the 2001 Queen’s Birthday Honours, he was awarded a Knighthood. In 2011, he was appointed Patron of the Cancer Stem Cell Research Institute at Cardiff University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --